Volume 72, Issue 12, Pages (December 2007)

Slides:



Advertisements
Similar presentations
Prognostic Significance of Declining Ankle-brachial Index Values in Patients with Suspected or Known Peripheral Arterial Disease H.H.H. Feringa, S.E. Karagiannis,
Advertisements

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants  C.A. Solid,
Beta blockers in the management of chronic kidney disease
Volume 69, Issue 5, Pages (March 2006)
C-reactive protein and dialysis access
C-reactive protein and dialysis access
Inflammation and wasting in chronic kidney disease: Partners in crime
Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis  Sanjeev Kumar, Stanley L.-S. Fan, Martin.
Volume 71, Issue 8, Pages (April 2007)
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Volume 73, Issue 4, Pages (February 2008)
Volume 70, Pages S21-S25 (December 2006)
Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?  Fu L. Luan, Diane E. Steffick,
The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease  Harm H.H. Feringa, MD, Stefanos.
Comorbidity and confounding in end-stage renal disease
D. Batlle, P. Ramadugu, M.J. Soler  Kidney International 
A new era in phosphate binder therapy: What are the options?
Volume 70, Issue 11, Pages (December 2006)
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Volume 70, Issue 12, Pages (December 2006)
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease  S. Bianchi, R. Bigazzi, V.M. Campese 
Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments  R. Mishler, J.J. Sands, N.J. Ofsthun,
The analysis of survival data: the Kaplan–Meier method
Volume 71, Issue 6, Pages (March 2007)
Volume 70, Issue 12, Pages (December 2006)
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Blood pressure targets in hemodialysis patients
Fructose intake as a risk factor for kidney stone disease
The third World Kidney Day: Looking back and thinking forward
Volume 72, Issue 1, Pages 8-10 (July 2007)
Extracorporeal therapy in sepsis: are we there yet?
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Microbiology and outcomes of peritonitis in North America
Methods for guideline development
Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes  J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.
The influence of polyvascular disease on the obesity paradox in vascular surgery patients  Jan-Peter van Kuijk, MD, Willem-Jan Flu, MD, Wael Galal, MD,
The global challenge of chronic kidney disease
V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen 
Reviewer Acknowledgment
Volume 71, Issue 4, Pages (February 2007)
Volume 71, Issue 12, Pages (June 2007)
Sanne E. Hoeks, MSc, Wilma J
Perioperative asymptomatic cardiac damage after endovascular abdominal aneurysm repair is associated with poor long-term outcome  Tamara A. Winkel, MD,
Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients  B. Bammens, P. Evenepoel, H. Keuleers,
Racial differences in survival of patients on dialysis
Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants  C.A. Solid,
Organ transplantation goes to the movies
Low triiodothyronine and survival in end-stage renal disease
Volume 72, Issue 2, Pages (July 2007)
Volume 72, Issue 8, Pages (October 2007)
Is it the low-protein diet or simply the salt restriction?
Charles A. Herzog  Kidney International 
Is complement a target for therapy in renal disease?
Urinalysis in Western culture: A brief history
Volume 70, Issue 3, Pages (August 2006)
Volume 71, Issue 9, Pages (May 2007)
Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate  S. Aime, C. Canavese, P. Stratta  Kidney International 
Fetuin-A is not associated with mortality in chronic kidney disease
Olaf Schouten, MD, Jeroen J. Bax, MD, Martin Dunkelgrun, MD, Harm H
Volume 70, Issue 5, Pages (September 2006)
Volume 70, Issue 3, Pages (August 2006)
Volume 72, Issue 11, Pages (December 2007)
Volume 70, Issue 10, Pages (November 2006)
The International Pediatric Peritonitis Registry: Starting to walk
Volume 69, Issue 8, Pages (April 2006)
In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression  B.O. Eriksen, O.C. Ingebretsen  Kidney.
E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins 
Volume 72, Issue 12, (December 2007)
Presentation transcript:

Volume 72, Issue 12, Pages 1527-1534 (December 2007) β-Blockers improve outcomes in kidney disease patients having noncardiac vascular surgery  G.M.J.M. Welten, M. Chonchol, S.E. Hoeks, O. Schouten, J.J. Bax, M. Dunkelgrün, Y.R.B.M. van Gestel, H.H.H. Feringa, R.T. van Domburg, D. Poldermans  Kidney International  Volume 72, Issue 12, Pages 1527-1534 (December 2007) DOI: 10.1038/sj.ki.5002554 Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 Kaplan–Meier estimate of overall survival by level of kidney function (CrCl) during 5.98±3.68 years of follow-up. Kidney International 2007 72, 1527-1534DOI: (10.1038/sj.ki.5002554) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 2 Kaplan–Meier estimate of overall survival by level of kidney function (CrCl) and β-blocker therapy during 5.98±3.68 years of follow-up. —β-Blocker use; . . . . . . . . No β-blocker use. Kidney International 2007 72, 1527-1534DOI: (10.1038/sj.ki.5002554) Copyright © 2007 International Society of Nephrology Terms and Conditions